Literature DB >> 30453454

Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study.

Victor E Staartjes1, Carlo Serra1, Giovanni Muscas2, Nicolai Maldaner1, Kevin Akeret1, Christiaan H B van Niftrik1, Jorn Fierstra1, David Holzmann3, Luca Regli1.   

Abstract

OBJECTIVEGross-total resection (GTR) is often the primary surgical goal in transsphenoidal surgery for pituitary adenoma. Existing classifications are effective at predicting GTR but are often hampered by limited discriminatory ability in moderate cases and by poor interrater agreement. Deep learning, a subset of machine learning, has recently established itself as highly effective in forecasting medical outcomes. In this pilot study, the authors aimed to evaluate the utility of using deep learning to predict GTR after transsphenoidal surgery for pituitary adenoma.METHODSData from a prospective registry were used. The authors trained a deep neural network to predict GTR from 16 preoperatively available radiological and procedural variables. Class imbalance adjustment, cross-validation, and random dropout were applied to prevent overfitting and ensure robustness of the predictive model. The authors subsequently compared the deep learning model to a conventional logistic regression model and to the Knosp classification as a gold standard.RESULTSOverall, 140 patients who underwent endoscopic transsphenoidal surgery were included. GTR was achieved in 95 patients (68%), with a mean extent of resection of 96.8% ± 10.6%. Intraoperative high-field MRI was used in 116 (83%) procedures. The deep learning model achieved excellent area under the curve (AUC; 0.96), accuracy (91%), sensitivity (94%), and specificity (89%). This represents an improvement in comparison with the Knosp classification (AUC: 0.87, accuracy: 81%, sensitivity: 92%, specificity: 70%) and a statistically significant improvement in comparison with logistic regression (AUC: 0.86, accuracy: 82%, sensitivity: 81%, specificity: 83%) (all p < 0.001).CONCLUSIONSIn this pilot study, the authors demonstrated the utility of applying deep learning to preoperatively predict the likelihood of GTR with excellent performance. Further training and validation in a prospective multicentric cohort will enable the development of an easy-to-use interface for use in clinical practice.

Entities:  

Keywords:  3T-iMRI = 3-T intraoperative MRI; AUC = area under the curve; CSS = cavernous sinus space; EOR = extent of resection; GTR = gross-total resection; ICD = intercarotid distance; NPV = negative predictive value; PA = pituitary adenoma; PPV = positive predictive value; deep learning; deep neural network; outcome prediction; pituitary adenoma; pituitary surgery; transsphenoidal surgery

Mesh:

Year:  2018        PMID: 30453454     DOI: 10.3171/2018.8.FOCUS18243

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  15 in total

1.  Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly.

Authors:  Yanghua Fan; Yansheng Li; Yichao Li; Shanshan Feng; Xinjie Bao; Ming Feng; Renzhi Wang
Journal:  Endocrine       Date:  2019-10-30       Impact factor: 3.633

2.  Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.

Authors:  Elena L Sorba; Victor E Staartjes; Stefanos Voglis; Lazar Tosic; Giovanna Brandi; Oliver Tschopp; Carlo Serra; Luca Regli
Journal:  Neurosurg Rev       Date:  2020-06-24       Impact factor: 3.042

Review 3.  Machine Learning in Pituitary Surgery.

Authors:  Vittorio Stumpo; Victor E Staartjes; Luca Regli; Carlo Serra
Journal:  Acta Neurochir Suppl       Date:  2022

4.  Machine Learning and Intracranial Aneurysms: From Detection to Outcome Prediction.

Authors:  Vittorio Stumpo; Victor E Staartjes; Giuseppe Esposito; Carlo Serra; Luca Regli; Alessandro Olivi; Carmelo Lucio Sturiale
Journal:  Acta Neurochir Suppl       Date:  2022

5.  Interpretable Machine Learning-Based Prediction of Intraoperative Cerebrospinal Fluid Leakage in Endoscopic Transsphenoidal Pituitary Surgery: A Pilot Study.

Authors:  Pier Paolo Mattogno; Valerio M Caccavella; Martina Giordano; Quintino G D'Alessandris; Sabrina Chiloiro; Leonardo Tariciotti; Alessandro Olivi; Liverana Lauretti
Journal:  J Neurol Surg B Skull Base       Date:  2022-01-16

6.  Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning.

Authors:  Lorenzo Ugga; Renato Cuocolo; Domenico Solari; Elia Guadagno; Alessandra D'Amico; Teresa Somma; Paolo Cappabianca; Maria Laura Del Basso de Caro; Luigi Maria Cavallo; Arturo Brunetti
Journal:  Neuroradiology       Date:  2019-08-02       Impact factor: 2.804

Review 7.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

8.  A systematic review on machine learning in sellar region diseases: quality and reporting items.

Authors:  Nidan Qiao
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

9.  Development of machine learning models to prognosticate chronic shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Giovanni Muscas; Tommaso Matteuzzi; Eleonora Becattini; Simone Orlandini; Francesca Battista; Antonio Laiso; Sergio Nappini; Nicola Limbucci; Leonardo Renieri; Biagio R Carangelo; Salvatore Mangiafico; Alessandro Della Puppa
Journal:  Acta Neurochir (Wien)       Date:  2020-07-08       Impact factor: 2.216

10.  Machine learning in neurosurgery: a global survey.

Authors:  Victor E Staartjes; Vittorio Stumpo; Julius M Kernbach; Anita M Klukowska; Pravesh S Gadjradj; Marc L Schröder; Anand Veeravagu; Martin N Stienen; Christiaan H B van Niftrik; Carlo Serra; Luca Regli
Journal:  Acta Neurochir (Wien)       Date:  2020-08-18       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.